Senthilnathan Palaniyandi

Statistics

Publications

Citations

H-Index

Active since

2005

Affiliations

Louisiana State University Health Sciences Center Shreveport(Current)

University of Madras

National University of Singapore

Loma Linda University

National University Hospital

Senthilnathan Palaniyandi is an author at Louisiana State University Health Sciences Center Shreveport specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2005–2023

Publications

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage

Lukas Schwab, Luise Goroncy, Senthilnathan Palaniyandi et al. · Nature Medicine · 2014 · 294 citations

Life Sciences, Immunology, Microbiology +17

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara et al. · Blood · 2009 · 162 citations · Full text

Medicine, Cancer Biology, Oncology +9

Therapeutic effect of paclitaxel and propolis on lipid peroxidation and antioxidant system in 7,12 dimethyl benz(a)anthracene-induced breast cancer in female Sprague Dawley rats

R. Padmavathi, Senthilnathan Palaniyandi, Dechen Chodon et al. · Life Sciences · 2005 · 100 citations

Medicine, Oncology, Pharmacology +17

Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo(a)pyrene induced experimental lung cancer

Senthilnathan Palaniyandi, R. Padmavathi, Syed Mumtaz Banu et al. · Chemico-Biological Interactions · 2005 · 64 citations

Medicine, Oncology, Pharmacology +14

Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion

Zhigang Xie, Lai-Fong Poon, Jianbiao Zhou et al. · Cancer Chemotherapy and Pharmacology · 2008 · 53 citations

Life Sciences, Cell Biology, Oncology +16

1–5 of 18